Feb. 20, 2014
/PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its fourth quarter and fiscal year 2013 financial results after the market close on
Thursday, February 27, 2014
. An investor conference call will follow on the same day at
4:30 p.m. ET
The conference call will be hosted by
, President and Chief Executive Officer, and
, Chief Operating Officer and Chief Financial Officer.
To participate in the call, please dial (877) 369-6586 (U.S. and
) or (253) 237-1165 (international). A live webcast will be available on the Investor Relations section of the corporate website at
A replay of the conference call will be available beginning
February 27, 2014
7:30 p.m. ET
and ending on
March 6, 2014
by dialing (855) 859-2056 (U.S. and
) or (404) 537-3406 (international), Conference ID Number: 3470651. A replay of the webcast will be available on the corporate website for one week, through
March 6, 2014
About Alimera Sciences, Inc.
Alimera Sciences, Inc., headquartered in
, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera's European operations are conducted from
by its wholly-owned subsidiary, Alimera Sciences Limited.
Investor Contact:ICR, LLC
SOURCE Alimera Sciences, Inc.